We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at the ARDD conference in Copenhagen last August. In August, Deep Origin ...

The most visible impact of AI seems to be in coding, but it could also be poised to disrupt other hard sciences.

The unveiling of the Isomorphic Labs Drug Design Engine (IsoDDE) represents a fundamental shift from merely predicting the ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

London-based Isomorphic Labs Ltd., a drug discovery-focused artificial intelligence startup that was spun out of Google LLC’s DeepMind unit just over two years ago, today announced key partnerships ...

Google DeepMind's groundbreaking new AI predicts not only the structure of proteins, ligands, DNA, RNA and "all of life's molecules," but how they'll interact. It promises a radical, revolutionary ...

How Isomorphic Labs Is Rewriting Drug Discovery. Google DeepMind spin-off Isomorphic Labs is building an AI drug design engine that it believes can“solve” all diseases. We spoke to its Chief Technolog ...

As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech hub of Cambridge. Founded in 2021 as a spinoff of Alphabet AI company ...

Google DeepMind and Isomorphic Labs have released AlphaFold 3, an advanced AI model designed to predict the structure and interactions of biological molecules, including proteins, DNA, RNA, and ...

Google DeepMind, the artificial intelligence company behind the popular AlphaFold tool, has published the next generation of the application’s protein structure prediction software. The new tool can ...